학술논문
Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing
Document Type
Review
Author
Source
In: Clinical, Cosmetic and Investigational Dermatology . (Clinical, Cosmetic and Investigational Dermatology, 2023, 16:221-229)
Subject
Language
English
ISSN
11787015